Joel Goode Email & Phone Number

Bulverde, Tx, Us

San Antonio, Texas Metropolitan Area

Texas Based

Building a team of experienced, high performance Area Business Managers committed to excellence and patient centered customer engagement, who thrive and deliver results in a biologic launch environment

Texas

Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterials to treat multi-drug resistant (MDR), gram-negative infections

Nationwide- Based In San Antonio, Texas

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

Central & Southwest- Based In Texas

We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace.

Western U.S.- Based In Texas

Leading biopharmaceutical company with portfolio of 13 innovative products to treat conditions like HIV/AIDs, liver disease & serious cardiovascular & respiratory illnesses, ~4K employees & annual revenues of $7B. Named by Business Week as 2009's #1 best-performing company).Promoted to lead, develop strategy & oversee sales revenue performance of >$100M/year for the West Division, more than half of the US market. Highly specialized customer segments, including pulmonology, cardiology & rheumatology. Managed team of 6 Region Directors and 45 Institutional & Therapeutic Specialist Representatives and budget of $10.5M.

Appointed to hire/manage 9 Institutional & Therapeutic Specialists and lead the design/implementation of business development strategy focused on Institution & Hospital-based PAH Centers of Excellence in TX & NM with specialties in Cardiology. Expertise in FDA-monitored products [REMS Program] & Specialty Pharmacy Distribution Model. Managed $1.3M annual operating budget.

Promoted to lead 9 Account Managers responsible for market segments that included Correctional Healthcare, VA Healthcare System/VISN coverage, DOD accounts and community & patient-focused groups throughout US & Puerto Rico. Oversaw promotion, sales and contracting for HIV & Hepatitis product portfolio with annual revenues of >$110M in specialized markets. Managed budget of $2.11M.

Promoted to lead 8-state Region in Managed Care Reimbursement; State & Government Affairs, including Medicaid & ADAP; Community Relations/Liaison; and product sales to corrections facilities.

Recruited to market infectious disease-focused product portfolio including AmBisome, Vistide & launch of Viread, Gilead's first FDA-approved anti-retroviral in territory.

Hired and Promoted to sell CNS & GI products to Neurologists, Psychiatrists, Gastroenterologists, Infectious Disease Specialists as well as hospitals & teaching institutions located in northeast FL & south GA.